Serving 500+ biopharmaceutical companies globally:
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
Serving 500+ biopharmaceutical companies globally:
Generated: July 23, 2017
What are the generic sources for glyburide and what is the scope of glyburide patent protection?
Glyburide is the generic ingredient in seven branded drugs marketed by Sanofi Aventis Us, Aurobindo Pharma, Heritage Pharms Inc, Actavis Elizabeth, Zydus Pharms Usa Inc, Pharmacia And Upjohn, Epic Pharma Llc, Sandoz, Impax Labs Inc, Pharmadax Inc, Teva, Hikma, Dava Pharms Inc, Mylan, and Bristol Myers Squibb, and is included in twenty-five NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.| Tradenames: | 7 |
| Patents: | 2 |
| Applicants: | 15 |
| NDAs: | 25 |
| Drug Master File Entries: see list | 20 |
| Suppliers / Packagers: see list | 44 |
| Bulk Api Vendors: see list | 84 |
| Clinical Trials: see list | 61 |
| Patent Applications: see list | 6,286 |
| Therapeutic Class: | Blood Glucose Regulators |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see low prices |
| DailyMed Link: | glyburide at DailyMed |
| Ingredient-type | Sulfonylurea Compounds |
| Drug Class | Sulfonylurea |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva | GLYBURIDE (MICRONIZED) | glyburide | TABLET;ORAL | 074686-001 | Apr 20, 1999 | AB | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Zydus Pharms Usa Inc | GLYBURIDE | glyburide | TABLET;ORAL | 206749-001 | May 10, 2016 | AB1 | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Hikma | GLYBURIDE (MICRONIZED) | glyburide | TABLET;ORAL | 075890-002 | Jul 31, 2003 | AB | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Impax Labs Inc | GLYBURIDE | glyburide | TABLET;ORAL | 206079-002 | Sep 30, 2015 | AB2 | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Bristol Myers Squibb | GLUCOVANCE | glyburide; metformin hydrochloride | TABLET;ORAL | 021178-003 | Jul 31, 2000 | AB | RX | Yes | No | 6,303,146*PED | ► Subscribe | Y | ► Subscribe | ||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | DIABETA | glyburide | TABLET;ORAL | 017532-003 | May 1, 1984 | 3,454,635 | ► Subscribe | ||||||||||||||||||||||
Pharmacia And Upjohn | MICRONASE | glyburide | TABLET;ORAL | 017498-002 | May 1, 1984 | 3,426,067 | ► Subscribe | ||||||||||||||||||||||
Pharmacia And Upjohn | GLYNASE | glyburide | TABLET;ORAL | 020051-001 | Mar 4, 1992 | 4,735,805 | ► Subscribe | ||||||||||||||||||||||
Pharmacia And Upjohn | GLYNASE | glyburide | TABLET;ORAL | 020051-004 | Sep 24, 1993 | 4,735,805 | ► Subscribe | ||||||||||||||||||||||
Pharmacia And Upjohn | MICRONASE | glyburide | TABLET;ORAL | 017498-002 | May 1, 1984 | 3,507,954 | ► Subscribe | ||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Serving 500+ biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Follow DrugPatentWatch:
Join the 22,097 others who get our Drug Patent Expiration Alerts:
